Chipotle (NYSE:CMG) Shares Approach Buyback Price as Salmonella Investigation Wipes Out $4.7 Billion
5 August 2026

Chipotle (NYSE:CMG) Shares Approach Buyback Price as Salmonella Investigation Wipes Out $4.7 Billion

NEW YORK, August 5, 2026, 07:15 EDT

  • Chipotle ended Tuesday’s session at $33.82, falling 9.7%, with 51.4 million shares traded.
  • Minnesota reported 110 cases; out of 84 patients interviewed, 75 said they had eaten at Chipotle.
  • The closing price is 3.9% higher than Chipotle’s Q2 average repurchase price of $32.55.

Chipotle Mexican Grill saw its equity value drop by roughly $4.66 billion on Tuesday, with shares sliding 9.7% to $33.82 after jalapeños were identified as a potential source in an outbreak. The NYSE regular session had not yet begun at the time of the report.

Stock chart for NYSE:CMG

The magnitude of the move indicates there is more at play than just ingredient replacement costs. It implies investors may be anticipating a potential nationwide traffic disruption. Chipotle’s shares are currently just 3.9% higher than the company’s latest buyback price.

Minnesota has reported 110 cases linked to the outbreak. Among 84 individuals interviewed, 75 said they had eaten at Chipotle between June 14 and July 14. Some of the other cases involved people who had visited various other Mexican-style eateries.

Chipotle identified a specific batch of jalapeños within its supply chain and pulled the peppers from impacted locations in Minnesota as well as additional states. The company sourced replacement peppers from alternative suppliers.

Market measureBenchmarkLatest figureDifference
Closing price$37.46 on Aug. 3$33.82 on Aug. 4-9.72%
July 30 earnings-reaction close$38.52$33.82-12.2%
Estimated market value$47.91 billion$43.26 billion-$4.66 billion
Trading volume19.6 million average51.44 million2.6 times
Q2 repurchase price$32.55 average$33.82 close+3.9%
Remaining authorization$1.70 billion$4.66 billion erasedRepresents 36.5%

Figures for market value and ratios reflect computations using closing prices, latest market capitalization, and company disclosures.

The company did not disclose which supplier was involved or specify the number of restaurants impacted. Minnesota epidemiologist Carlota Medus stated officials were “not concerned about Chipotle” following the company’s actions. The FDA is conducting the traceback probe. Reuters

The reassurance comes as operations remain on shaky ground. Second-quarter revenue increased 9.3% to $3.35 billion. Comparable sales were up 2.2%, while the restaurant-level margin declined by 220 basis points.

Transactions increased by 1.0%, continuing their rebound. Chief Executive Scott Boatwright described the improvement as “encouraging” following investments in the menu and rewards program. Margins continued to face pressure from elevated beef, freight and labor costs. Chipotle InvestorRoom

Operating measureQ2 2025Q2 2026Change
Revenue$3.063 billion$3.349 billion+9.3%
Restaurant-level operating margin27.4%25.2%-220 basis points
Food, beverage and packaging costs28.9% of revenue29.7%+80 basis points
Labor costs24.7% of revenue25.0%+30 basis points
Net income$436.1 million$403.5 million-7.5%
Adjusted diluted EPS$0.33$0.33No change

The investigation comes after another incident affecting the food sector. A distinct cyclospora outbreak reduced Chipotle’s sales in late July by roughly 2%. Chipotle stated the affected products were not part of its menu.

Chief Financial Officer Adam Rymer stated that the leadership expected cautious sentiment to persist through the remainder of the quarter. Bernstein analyst Danilo Gargiulo cautioned that third-quarter growth may fall short of his projection “if the situation does escalate.” Reuters

Capital returns serve as a benchmark but do not guarantee comprehensive protection. Chipotle repurchased $630.7 million worth of stock in Q2, paying an average of $32.55 per share. The company’s remaining buyback authorization represents only 36.5% of the estimated value lost on Tuesday.

Restaurant companyLatest available priceMarket valueTrailing P/EMove versus prior close
Chipotle Mexican Grill $33.82$43.3 billion30.5 times-9.72%
Cava Group $63.44$7.5 billion122.0 times-1.64%
McDonald’s $268.34$191.5 billion22.1 times+1.15%
Restaurant Brands International $73.88$33.9 billion26.1 times+1.29%
Yum Brands $147.68$40.7 billion23.8 times-0.81%

Quotes reflect the most recent data prior to the start of regular trading.

Chipotle still trades at a valuation premium over established restaurant chains, despite the decline. Its multiple is above those of McDonald’s, Restaurant Brands and Yum. Cava continues to stand out as the higher-growth exception.

Upcoming indicators include traffic figures and further updates on the case. Investors are monitoring to see if August visitation remains steady and if guidance is maintained. If traffic levels are stable, Tuesday’s selloff could appear excessive.

Risks exist in both directions. An increase in cases, a supplier recall, or a decline in visits may impact Q3 comps negatively. Quicker containment efforts might drive a recovery, although the source has not yet been identified.

TS2 TECH • EXTENDED COVERAGE

Further analysis

Could the salmonella investigation interrupt Chipotle’s sales recovery?

Chipotle shares ended August 4 at $33.82, falling 9.7%. Minnesota has identified 110 cases, with 75 out of 84 interviewed individuals reporting they had eaten at Chipotle. Jalapeño peppers are still being investigated as a potential link, but have not been confirmed as the source. Officials say there is no ongoing risk after Chipotle swapped out the suspected ingredients. Chipotle reported a 1.0% increase in second-quarter transactions and raised its full-year comparable sales outlook to the low single digits. The investigation poses a challenge to that recovery. Reuters

Is it possible for rising revenue to once more lead to higher earnings?

Second-quarter revenue grew by 9.3%, but adjusted earnings per share held steady at $0.33. Restaurant-level operating margin declined by 220 basis points to 25.2%. Food costs were up 80 basis points and labor increased by 30. Beef, freight, and wage inflation continue to be the key cost pressures. Margins need to stabilize for expansion to lead to higher earnings per share. SEC

Following the decline, is CMG now trading at an appealing valuation?

CMG is priced at $33.82, representing about 29.4 times FactSet’s $1.15 EPS forecast for 2026. FactSet’s consensus price target of $44.05 signals potential upside of nearly 30%. Analyst price targets span from $36 to $52, indicating a significant variation in projections. Consensus maintains an Overweight rating, with no analysts rating the stock as Underweight or Sell. Current valuation reflects expectations for renewed earnings expansion. The Wall Street Journal

If comparable sales slow, can newly opened restaurants maintain their growth?

New restaurant launches accounted for the majority of Chipotle’s 9.3% revenue growth in Q2. The company added 100 company-owned locations, with 80 featuring Chipotlanes. Management projects 350 to 370 new openings in 2026, including 10 to 15 locations run by international partners. Execution remains key as Q2 comparable sales climbed just 2.2%. Chipotle InvestorRoom

Might buybacks help limit further declines in share prices?

Chipotle bought back $630.7 million worth of shares in Q2, paying an average of $32.55 each. As of August 4, shares closed just 3.9% higher than that price. The remaining buyback authorization amounts to $1.7 billion, also roughly 3.9% of the total market capitalization. That scale is significant. Still, it does not offset declines in traffic or profit margins. SEC

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY

Pfizer

NYSE: PFE 93 / 100
#2 TACTICAL BUY

AMD

NASDAQ: AMD 91 / 100
#3 STRONG BUY

AerCap

NYSE: AER 90 / 100
#4 BUY ONLY ON PULLBACK

Booking Holdings

NASDAQ: BKNG 88 / 100
#5 BUY ON WEAKNESS

Visa

NYSE: V 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Kratos (NASDAQ:KTOS) rises as missile, engine sales fuel Q2 outperformance
Previous Story

Kratos (NASDAQ:KTOS) rises as missile, engine sales fuel Q2 outperformance

Shopify (NASDAQ:SHOP) Shares Rally Nearly 25% After Q3 Forecast Boosts Valuation
Next Story

Shopify (NASDAQ:SHOP) Shares Rally Nearly 25% After Q3 Forecast Boosts Valuation